Itraconazole
This broad-spectrum triazole antifungal is used to treat various fungal infections including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. It works by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. It has many drug interactions due to its inhibition of liver cytochrome P450 enzymes.
आणविक भार
705.6000 g/mol
LogP
5.70
TPSA
101.00 Ų
लिपिंस्की RO5
अनुत्तीर्ण
चिकित्सीय क्षेत्र
क्रिया का तंत्र
Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.
2D संरचना
Cite this structure
Embed this structure
SMILES
CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
InChI
InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3
Molecular Formula
C35H38Cl2N8O4
HBD / HBA
- / 9
घूर्णनीय बंधन
11
भारी परमाणु
49
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
अक्सर पूछे जाने वाले प्रश्न
This broad-spectrum triazole antifungal is used to treat various fungal infections including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. It works by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. It has many drug interactions due to its inhibition of liver cytochrome P450 enzymes.
Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.
Yes, Itraconazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL64391. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 55283. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="itraconazole"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/itraconazole/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/itraconazole/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/itraconazole/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="itraconazole"></drugfyi-drug>